The Impact of CheckMate-205 for Patients With Classical Hodgkin Lymphoma

June 28, 2016
Anas Younes, MD

Anas Younes, MD, medical oncologist at Memorial Sloan Kettering Cancer Center in New York, discusses the potential impact of CheckMate-205 nivolumab as a treatment for patients with Hodgkin lymphoma.